The U.S. Food and Drug Administration (FDA) has approved a new drug for the treatment of moderate-to-severe pain that is a non-opioid and carries less risks of addiction than opioids.
AI can summarize doctor-patient interactions, helping physicians produce visit notes for records and follow-up care. LLMs can even do this in the doctor’s voice. It’s not flawless, though.
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, will ...